Perihilar Cholangiocarcinoma – Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers
Authors:
Top Cited Papers
- 29 July 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 274 (5) , 780-788
Abstract
Objective: The aim of this study was to define robust benchmark values for the surgical treatment of perihilar cholangiocarcinomas (PHC) to enable unbiased comparisons. Background: Despite ongoing efforts, postoperative mortality and morbidity remains high after complex liver surgery for PHC. Benchmark data of best achievable results in surgical PHC treatment are however still lacking. Methods: This study analyzed consecutive patients undergoing major liver surgery for PHC in 24 high-volume centers in 3 continents over the recent 5-year period (2014–2018) with a minimum follow-up of 1 year in each patient. Benchmark patients were those operated at high-volume centers (≥50 cases during the study period) without the need for vascular reconstruction due to tumor invasion, or the presence of significant co-morbidities such as severe obesity (body mass index ≥35), diabetes, or cardiovascular diseases. Benchmark cutoff values were derived from the 75th or 25th percentile of the median values of all benchmark centers. Results: Seven hundred eight (39%) of a total of 1829 consecutive patients qualified as benchmark cases. Benchmark cut-offs included: R0 resection ≥57%, postoperative liver failure (International Study Group of Liver Surgery): ≤35%; in-hospital and 3-month mortality rates ≤8% and ≤13%, respectively; 3-month grade 3 complications and the CCI: ≤70% and ≤30.5, respectively; bile leak-rate: ≤47% and 5-year overall survival of ≥39.7%. Centers operating mostly on complex cases disclosed better outcome including lower post-operative liver failure rates (4% vs 13%; P = 0.002). Centers from Asia disclosed better outcomes. Conclusion: Surgery for PHC remains associated with high morbidity and mortality with now the availability of benchmark values covering 21 outcome parameters, which may serve as key references for comparison in any future analyses of individuals, group of patients or centers.Keywords
This publication has 31 references indexed in Scilit:
- Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinomaBritish Journal of Surgery, 2012
- Improvement in Perioperative and Long-term Outcome After Surgical Treatment of Hilar CholangiocarcinomaArchives of Surgery, 2012
- Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar CholangiocarcinomaAnnals of Surgical Oncology, 2011
- Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)HPB, 2011
- Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver SurgerySurgery, 2011
- New staging system and a registry for perihilar cholangiocarcinomaHepatology, 2011
- Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancerBritish Journal of Surgery, 2010
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 yearsJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Classification of Surgical ComplicationsAnnals of Surgery, 2004